Thus, in the early stages of sepsis treatment, the control of the VSIG4 positive macrophages is considered important to prevent thymus damage and to maintain patient immunity for the treatment process or/and to prevent recurrence after a treatment. Here, VSIG4 is linked to Sepsis.